ISIS Leader Al-Baghdadi Reported Dead — for at Least the

New Post Public Reply Private Reply Replies (0) Message Board
nlightn
208
ISIS Leader Al-Baghdadi Reported Dead — for at Least the 7th Time in 12 Years
Oct 29, 2019
S.M. Gibson

Oddly, this is not the first instance in which al-Baghdadi was reportedly killed over the years.


(TMU) — President Donald Trump has formally announced that Abu Bakr al-Baghdadi, self-proclaimed leader of ISIS, is dead from suicide. The infamous terrorist reportedly detonated an explosive vest on Saturday night as U.S. Special Forces raided a compound in the Syrian Province of Idlib.

Along with obliterating the ISIS figurehead, the blast also killed three children, according to the U.S. government.

“Baghdadi was vicious and violent, and he died in a vicious and violent way, as a coward, running and crying,” Trump said. “He died like a dog, he died like a coward.”

Oddly, this is not the first instance in which al-Baghdadi was reportedly killed or severely wounded over the years—and it may not be the last.

Iraqi officials first reported his death in May 2007. According to a CNN report, Maj. Gen. William Caldwell said it was not known who Baghdadi was or if he even existed, and the Islamic State denied al-Baghdadi had been killed.

Two months later, military spokesperson Brigadier-General Kevin Bergner told a news conference that al-Baghdadi did not exist at all, Reuters reported. According to Bergner’s sources, the leader of ISIS was given an Iraqi name (Baghdadi, meaning “from Baghdad”) so the group’s foreign influence and leadership could be masked from its followers.

Reuters reported in 2009 that Iraqi forces had captured al-Baghdadi, something ISIS denied. He was then reported dead by then-Iraqi Prime Minister Nuri al-Maliki in April 2010, following an airstrike U.S. Vice-President Joe Biden referred to as a “potentially devastating blow.”

Baghdadi was once again reported at large in Iraq until Iraqi officials told Al-Jazeera they had again arrested Baghdadi in December 2012.

Casting further doubt on al-Baghdadi’s existence, the ISIS leader rarely showed his face on camera and in 2014, he made his one known public appearance, according to the Independent.

Then in November 2014, somehow managing to evade his arrest, al-Baghdadi was reported “critically wounded” in an airstrike. Just five months later, he was “seriously wounded” in another air strike in April 2015. There are further reports that Baghdadi was killed in 2016, as well.

In May of 2017, the ISIS leader was also reportedly killed in Syria by Russian airstrikes, according to the Russian Defense Ministry and Syrian state television.

Less than a year later, a senior Iraqi official stated that al-Baghdadi was severely wounded in an air raid in Northwestern Syria in February 2018. The Iraqi official added that the ISIS leader suffers from “injuries, diabetes and fractures to the body and legs that prevent him from walking without assistance.”

More recently, al-Baghdadi was allegedly shown in an 18-minute long video released by an Islamic State media group in April of 2019. Various audio messages that were reportedly from al-Baghdadi have been released through the years, with the last being in 2019. However, the authenticity of those messages were not all verified, according the the BBC.

The United States also reportedly had him in their custody as far back as 2004. According to the Intercept:

“Days later, the Pentagon confirmed that Baghdadi was only in U.S. custody for 10 months, from February to December 2004. The Department of Defense told the fact-checking website PunditFact in a statement that Baghdadi was held at Camp Bucca. ‘A Combined Review and Release Board recommended ‘unconditional release’ of this detainee and he was released from U.S. custody shortly thereafter. We have no record of him being held at any other time.’”

Some have even reported that al-Baghdadi was in U.S. custody in 2009, though Politifact cast doubt on this particular claim after the Defense Department was asked to confirm the story and clarified that he was released in 2004, not 2009.

The media and government has obviously created a cycle of kill-capture-injure of a single person all while the general public has never seen more than brief snippets of the apparently immortal boogeyman.

The al-Baghdadi narrative makes Orwell’s 1984 look tame in comparison and, if history is any indicator, this is not the last time we’ve heard from al-Baghdadi.

A timeline of the al-Baghdadi narrative:
2004 – Al-Baghdadi was in U.S. custody
2007 – Iraqi officials report the death of al-Baghdadi
2007 – U.S. Major General William Caldwell said it was not known who al-Baghdadi was or if he even existed
2007 – Brigadier-General Kevin Bergner told a news conference that al-Baghdadi did not exist at all
2009 – Reuters reports that Iraqi forces had captured al-Baghdadi
2010 – Al-Baghdadi is reported dead by Iraqi Prime Minister Nuri al-Maliki from an airstrike
2012 – Al-Baghdadi is captured in Iraq
2014 – Al-Baghdadi made his only alleged public appearance in Mosul in June
2014 – Al-Baghdadi is reportedly killed by a U.S. airstrike in September
2014 – Al-Baghdadi is ‘critically wounded‘ from air strikes near Mosul in November
2015 – Al-Baghdadi is once again ‘seriously wounded‘ from a U.S. air strike near Nineveh
2016 – Al-Baghdadi is reportedly killed again by coalition air strikes in Raqqa
2017 – Al-Baghdadi is wounded from an airstrike and has to relinquish control of ISIS for five months
2017 – Al-Baghdadi is killed yet again by Russian airstrikes in Syria
2018 – Al-Baghdadi is ‘severely wounded‘ in an air raid
2019 – Al-Baghdadi allegedly appears in a video released by an Islamic State media group
2019 – Al-Baghdadi kills himself during U.S. raid
The Russian military has dismissed Trump’s al-Baghdadi speech as propaganda, while Iran’s Minister of Information and Communications Technology, Mohammad-Javad Azari Jahromi, declared that the U.S. had simply destroyed its “own creature.”

By S.M. Gibson | Creative Commons | TheMindUnleashed.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Spruce Point's Strong Sell Rating Casts Doubt on Construction Partners

Updated Category News Views 116

Spruce Point's Strong Sell Opinion on Construction Partners Inc Spruce Point Capital Management has recently issued a compelling report regarding Construction Partners Inc (NASDAQ: ROAD), a company recognized for its expertise in infrastructure and road construction. This report voices a strong sell recommendation, reflecting serious concerns over the company's current...

Continue Reading
Celebrating Excellence in Healthcare: Press Ganey's Honorees

Updated Category News Views 344

Celebrating the Executive Human Experience Award Winners Press Ganey, an industry leader dedicated to enhancing healthcare experiences, recently celebrated exceptional achievements in the field. During its annual conference, the Executive Human Experience Awards recognized extraordinary contributions from professionals and organizations that prioritize patient, consumer,...

Continue Reading
Commercial Vehicle Market Growth Driven by Technology Advancements

Updated Category News Views 122

Commercial Vehicle Market Growth and Projections The global commercial vehicle market is on an upward trajectory, with sales expected to reach 3.5 million units by 2025. The anticipated Year-over-Year (YoY) growth of 4.4% from 2024 highlights the increasing demand for medium and heavy commercial vehicles. This trend is being driven by several factors, including...

Continue Reading
Atos Receives Prestigious EcoVadis Platinum Medal Again

Updated Category News Views 195

Let’s not beat around the bush—Atos is doing something right in the sustainability game. They've bagged the EcoVadis Platinum Medal for five years running. Yep, that’s a serious flex in today’s corporate climate where ‘green’ isn’t just a buzzword; it’s almost an obligation if you want to stay relevant. The Metrics Behind Atos's Shine Scoring a...

Continue Reading
Power Metallic Mines Updates Shareholder Meeting Outcomes

Updated Category News Views 157

Power Metallic Mines Reports on AGSM Meeting Outcomes Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) expressed satisfaction with the voting outcomes from its Annual General and Special Meeting ("AGSM") that took place recently. The meeting gathered shareholders to discuss essential business items and elect members to the Board of...

Continue Reading